FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl

European Respiratory Journal

Volumn 38, Issue 1, 2011, Pages 78-88

  Wang, L ^a   Chiang, E T ^a   Simmons, J T ^a   Garcia, J G N ^a   Dudek, S M ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

c Abl tyrosine kinase; FTY720; Junctional complexes; Vascular endothelium; Vascular permeability

Indexed keywords

ABELSON KINASE; BETA CATENIN; CLAUDIN 5; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; FINGOLIMOD; FOCAL ADHESION KINASE; OCCLUDIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN ZO1; SMALL INTERFERING RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FOCAL ADHESION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG ENDOTHELIUM; MEMBRANE TRANSPORT; PERMEABILITY BARRIER; PRIORITY JOURNAL;

ADHERENS JUNCTIONS; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LUNG; LYSOPHOSPHOLIPIDS; PERMEABILITY; PHOSPHORYLATION; PROPYLENE GLYCOLS; PROTO-ONCOGENE PROTEINS C-ABL; PULMONARY ARTERY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOSINE; SUBCELLULAR FRACTIONS; TIGHT JUNCTIONS;

EID: 79960166600     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00047810     Document Type: Article

References (54)

1. Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009; 77: 39-45.
2. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91: 1487-1500. (Pubitemid 32900340)
3. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693. (Pubitemid 41464707)
4. Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001; 108: 689-701. (Pubitemid 32906197)
5. Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004; 169: 1245-1251. (Pubitemid 38680403)
6. McVerry BJ, Peng X, Hassoun PM, et al. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 2004; 170: 987-993. (Pubitemid 39425695)
7. Singleton PA, Dudek SM, Ma SF, et al. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006; 281: 34381-34393. (Pubitemid 46036646)
8. Dudek SM, Jacobson JR, Chiang ET, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004; 279: 24692-24700. (Pubitemid 38725337)
9. Shikata Y, Birukov KG, Birukova AA, et al. Involvement of sitespecific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J 2003; 17: 2240-2249. (Pubitemid 37509580)
10. Romer LH, Birukov KG, Garcia JG. Focal adhesions: paradigm for a signaling nexus. Circ Res 2006; 98: 606-616.
11. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999; 99: 301-312. (Pubitemid 29519909)
12. Xu M, Waters CL, Hu C, et al. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VEcadherin but requires cell spreading and Rho kinase. Am J Physiol Cell Physiol 2007; 293: C1309-C1318. (Pubitemid 47556738)
13. Lee JF, Zeng Q, Ozaki H, et al. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate-mediated endothelial chemotaxis and barrier integrity. J Biol Chem 2006; 281: 29190-29200. (Pubitemid 44507063)
14. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002; 296: 346-349. (Pubitemid 34303689)
15. Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010; 362: 402-415.
16. Kappos L, Radue EW, O'Connor P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010; 362: 387-401.
17. Dudek SM, Camp SM, Chiang ET, et al. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal 2007; 19: 1754-1764. (Pubitemid 46935431)
18. Hinck L, Näthke IS, Papkoff J, et al. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994; 125: 1327-1340. (Pubitemid 24189536)
19. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86: 279-367.
20. Pokutta S, Weis WI. Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu Rev Cell Dev Biol 2007; 23: 237-261.
21. Sun X, Shikata Y, Wang L, et al. Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. Microvasc Res 2009; 77: 304-313.
22. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004; 84: 869-901. (Pubitemid 38823769)
23. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-293. (Pubitemid 33676971)
24. Morita K, Sasaki H, Furuse M, et al. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999; 147: 185-194. (Pubitemid 30211806)
25. Carmeliet P, Lampugnani MG, Moons L, et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999; 98: 147-157. (Pubitemid 29344903)
26. Farhadi A, Keshavarzian A, Ranjbaran Z, et al. The role of protein kinase C isoforms in modulating injury and repair of the intestinal barrier. J Pharmacol Exp Ther 2006; 316: 1-7. (Pubitemid 41832574)
27. Birukova AA, Zagranichnaya T, Alekseeva E, et al. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. J Cell Physiol 2008; 215: 715-724. (Pubitemid 351632693)
28. Garcia JG, Schaphorst KL, Verin AD, et al. Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. J Appl Physiol 2000; 89: 2333-2343.
29. Rentsendorj O, Mirzapoiazova T, Adyshev D, et al. Role of vasodilator-stimulated phosphoprotein in cGMP-mediated protection of human pulmonary artery endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 2008; 294: L686-L697. (Pubitemid 351520101)
30. Woodring PJ, Hunter T, Wang JY. Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci 2003; 116: 2613-2626. (Pubitemid 36857215)
31. Huang X, Wu D, Jin H, et al. Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. J Cell Biol 2008; 183: 711-723.
32. Wu S, Cioffi EA, Alvarez D, et al. Essential role of a Ca2+-selective, store-operated current (ISOC) in endothelial cell permeability: determinants of the vascular leak site. Circ Res 2005; 96: 856-863. (Pubitemid 40604969)
33. Troyanovsky B, Alvarez DF, King JA, et al. Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner. Am J Physiol Lung Cell Mol Physiol 2008; 294: L266-L275. (Pubitemid 351253363)
34. Sarai K, Shikata K, Shikata Y, et al. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins. Am J Physiol Cell Physiol 2009; 297: C945-C954.
35. Vandenbroucke E, Mehta D, Minshall R, et al. Regulation of endothelial junctional permeability. Ann NY Acad Sci 2008; 1123: 134-145. (Pubitemid 351431312)
36. Van Itallie CM, Anderson JM. The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc 2004; 1: 138-141.
37. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161: 653-660. (Pubitemid 36578587)
38. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-1788. (Pubitemid 24012933)
39. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 2001; 280: H434-H440.
40. Wallez Y, Huber P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 2008; 1778: 794-809. (Pubitemid 351317803)
41. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6: 56-68. (Pubitemid 40064899)
42. Wu MH. Endothelial focal adhesions and barrier function. J Physiol 2005; 569: 359-366. (Pubitemid 41830107)
43. Braren R, Hu H, Kim YH, et al. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 2006; 172: 151-162. (Pubitemid 43042637)
44. Harrington EO, Shannon CJ, Morin N, et al. PKCd regulates endothelial basal barrier function through modulation of RhoA GTPase activity. Exp Cell Res 2005; 308: 407-421.
45. Moldobaeva A, Welsh-Servinsky LE, Shimoda LA, et al. Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L919-L930. (Pubitemid 43725054)
46. Liu Q, Zhao X, Frissora F, et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 2008; 111: 275-284.
47. Tar K, Csortos C, Czikora I, et al. Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure. J Cell Biochem 2006; 98: 931-953. (Pubitemid 43993408)
48. Koleske AJ, Gifford AM, Scott ML, et al. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 1998; 21: 1259-1272. (Pubitemid 29022529)
49. Matsubara T, Myoui A, Ikeda F, et al. Critical role of cortactin in actin ring formation and osteoclastic bone resorption. J Bone Miner Metab 2006; 24: 368-372. (Pubitemid 44306172)
50. Neviani P, Santhanam R, Oaks JJ, et al. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J Clin Invest 2007; 117: 2408-2421. (Pubitemid 47494343)
51. Bradley WD, Koleske AJ. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts. J Cell Sci 2009; 122: 3441-3454.
52. Zandy NL, Playford M, Pendergast AM. Abl tyrosine kinases regulate cell - cell adhesion through Rho GTPases. Proc Natl Acad Sci USA 2007; 104: 17686-17691. (Pubitemid 350210895)
53. Boyle SN, Michaud GA, Schweitzer B, et al. A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 2007; 17: 445-451.
54. Dudek SM, Chiang ET, Camp SM, et al. Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell 2010; 21: 4042-4056.